Centene (1CNC) Stock Forecast & Price Target

Compare

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1CNC Analyst Ratings

Hold

4 Buy

10 Hold

2 Sell

Based on 16 analysts giving stock ratings to

Centene

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1CNC Stock 12 Month Forecast

Average Price Target

€34.27

▲(7.28% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for Centene in the last 3 months. The average price target is €34.27 with a high forecast of €39.11 and a low forecast of €24.33. The average price target represents a 7.28% change from the last price of €31.94.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"21":"€21","68":"€68","32.75":"€32.8","44.5":"€44.5","56.25":"€56.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":39.10680045,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€39.11</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.2662475943,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€34.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.33312028,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€24.33</span>\n  </div></div>","useHTML":true}}],"tickPositions":[21,32.75,44.5,56.25,68],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.43,31.09744618846154,31.764892376923076,32.43233856538461,33.09978475384615,33.76723094230769,34.43467713076923,35.10212331923077,35.76956950769231,36.43701569615385,37.10446188461539,37.77190807307692,38.43935426153846,{"y":39.10680045,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.43,30.725095968792306,31.020191937584613,31.315287906376923,31.61038387516923,31.905479843961537,32.20057581275385,32.49567178154615,32.79076775033846,33.08586371913077,33.380959687923074,33.676055656715384,33.97115162550769,{"y":34.2662475943,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.43,29.961009252307694,29.492018504615384,29.023027756923078,28.55403700923077,28.085046261538462,27.616055513846153,27.147064766153846,26.678074018461537,26.20908327076923,25.74009252307692,25.271101775384615,24.802111027692305,{"y":24.33312028,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":67.8,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.78,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.98,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.17,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.99,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.31,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.14,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.31,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.695,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.385,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.595,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.43,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€39.11

Average Price Target€34.27

Lowest Price Target€24.33

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Scott Fidel

Goldman Sachs

€28.35→€32.65

Sell

2.22%

Upside

Reiterated

10/31/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (NYSE: EW), Centene (NYSE: CNC) and Nuvalent (NASDAQ: NUVL)

Ryan Langston

TD Cowen

€25.78→€29.21

Hold

-8.54%

Downside

Assigned

10/31/25

Centene (CNC) Receives a Hold from TD Cowen

David S Macdonald

Truist Financial

€36.09→€38.66

Buy

21.05%

Upside

Reiterated

10/30/25

Truist Financial Sticks to Its Buy Rating for Centene (CNC)

Michael Wiederhorn

Oppenheimer

€36.95→€38.66

Buy

21.05%

Upside

Reiterated

10/30/25

Centene price target raised to $45 from $43 at OppenheimerCentene price target raised to $45 from $43 at Oppenheimer

A.J. Rice

UBS

€36.95→€36.09

Hold

12.98%

Upside

Reiterated

10/30/25

Centene price target lowered to $42 from $43 at UBSCentene price target lowered to $42 from $43 at UBS

Soren Coverra

TR | OpenAI - 4o

€30.93→€33.51

Hold

4.91%

Upside

Reiterated

10/30/25

AI Generated ArticleAI Generated Article

Unknown Analyst

Roth MKM

Not Ranked

Roth MKM

€36.95→€38.66

Buy

21.05%

Upside

Reiterated

10/30/25

Roth MKM Reaffirms Their Buy Rating on Centene (CNC)

Kevin Fischbeck

Bank of America Securities

€24.06

Sell

-24.68%

Downside

Reiterated

10/29/25

Centene's Uncertain Future: Sell Rating Amid Medicaid and Exchange Challenges

Jason Cassorla

Guggenheim

―

Hold

―

Reiterated

10/16/25

Guggenheim Sticks to Their Hold Rating for Centene (CNC)

Lance Wilkes

Bernstein

€30.93

Buy

-3.16%

Downside

Reiterated

10/16/25

Centene (CNC) Receives a Buy from Bernstein

Erin Wright

Morgan Stanley

€24.06→€32.65

Hold

2.22%

Upside

Reiterated

10/14/25

Centene price target raised to $38 from $28 at Morgan StanleyCentene price target raised to $38 from $28 at Morgan Stanley

Sarah James

Cantor Fitzgerald

€32.65

Hold

2.22%

Upside

Reiterated

10/10/25

Cantor Fitzgerald Keeps Their Hold Rating on Centene (CNC)Cantor Fitzgerald analyst Sarah James reiterated a Neutral rating and $38.00 price target on Centene (NYSE: CNC).

Ann Hynes

Mizuho Securities

€24.06→€34.37

Hold

7.60%

Upside

Reiterated

10/08/25

Centene price target raised to $40 from $28 at MizuhoCentene price target raised to $40 from $28 at Mizuho

Stephen Baxter

Wells Fargo

€25.78→€35.23

Hold

10.29%

Upside

Reiterated

10/06/25

Centene price target raised to $41 from $30 at Wells FargoCentene price target raised to $41 from $30 at Wells Fargo

Andrew Mok CFA

Barclays

€27.83→€28.35

Hold

-11.23%

Downside

Reiterated

09/11/25

Centene (CNC) Gets a Hold from Barclays

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Scott Fidel

Goldman Sachs

€28.35→€32.65

Sell

2.22%

Upside

Reiterated

10/31/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (NYSE: EW), Centene (NYSE: CNC) and Nuvalent (NASDAQ: NUVL)

Ryan Langston

TD Cowen

€25.78→€29.21

Hold

-8.54%

Downside

Assigned

10/31/25

Centene (CNC) Receives a Hold from TD Cowen

David S Macdonald

Truist Financial

€36.09→€38.66

Buy

21.05%

Upside

Reiterated

10/30/25

Truist Financial Sticks to Its Buy Rating for Centene (CNC)

Michael Wiederhorn

Oppenheimer

€36.95→€38.66

Buy

21.05%

Upside

Reiterated

10/30/25

Centene price target raised to $45 from $43 at OppenheimerCentene price target raised to $45 from $43 at Oppenheimer

A.J. Rice

UBS

€36.95→€36.09

Hold

12.98%

Upside

Reiterated

10/30/25

Centene price target lowered to $42 from $43 at UBSCentene price target lowered to $42 from $43 at UBS

Soren Coverra

TR | OpenAI - 4o

€30.93→€33.51

Hold

4.91%

Upside

Reiterated

10/30/25

AI Generated ArticleAI Generated Article

Unknown Analyst

Roth MKM

Not Ranked

Roth MKM

€36.95→€38.66

Buy

21.05%

Upside

Reiterated

10/30/25

Roth MKM Reaffirms Their Buy Rating on Centene (CNC)

Kevin Fischbeck

Bank of America Securities

€24.06

Sell

-24.68%

Downside

Reiterated

10/29/25

Centene's Uncertain Future: Sell Rating Amid Medicaid and Exchange Challenges

Jason Cassorla

Guggenheim

―

Hold

―

Reiterated

10/16/25

Guggenheim Sticks to Their Hold Rating for Centene (CNC)

Lance Wilkes

Bernstein

€30.93

Buy

-3.16%

Downside

Reiterated

10/16/25

Centene (CNC) Receives a Buy from Bernstein

Erin Wright

Morgan Stanley

€24.06→€32.65

Hold

2.22%

Upside

Reiterated

10/14/25

Centene price target raised to $38 from $28 at Morgan StanleyCentene price target raised to $38 from $28 at Morgan Stanley

Sarah James

Cantor Fitzgerald

€32.65

Hold

2.22%

Upside

Reiterated

10/10/25

Cantor Fitzgerald Keeps Their Hold Rating on Centene (CNC)Cantor Fitzgerald analyst Sarah James reiterated a Neutral rating and $38.00 price target on Centene (NYSE: CNC).

Ann Hynes

Mizuho Securities

€24.06→€34.37

Hold

7.60%

Upside

Reiterated

10/08/25

Centene price target raised to $40 from $28 at MizuhoCentene price target raised to $40 from $28 at Mizuho

Stephen Baxter

Wells Fargo

€25.78→€35.23

Hold

10.29%

Upside

Reiterated

10/06/25

Centene price target raised to $41 from $30 at Wells FargoCentene price target raised to $41 from $30 at Wells Fargo

Andrew Mok CFA

Barclays

€27.83→€28.35

Hold

-11.23%

Downside

Reiterated

09/11/25

Centene (CNC) Gets a Hold from Barclays

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Centene

1 Month

xxx

Success Rate

31/52 ratings generated profit

Average Return

+1.63%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 59.62% of your transactions generating a profit, with an average return of +1.63% per trade.

3 Months

xxx

Success Rate

35/52 ratings generated profit

Average Return

+3.71%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 67.31% of your transactions generating a profit, with an average return of +3.71% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

28/52 ratings generated profit

Average Return

+6.95%

reiterated a buy rating 8 days ago

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of +6.95% per trade.

2 Years

xxx

Success Rate

29/52 ratings generated profit

Average Return

+5.68%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 55.77% of your transactions generating a profit, with an average return of +5.68% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1CNC Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1CNC has received 11 Buy Ratings, 22 Hold Ratings, and 4 Sell Ratings. 1CNC average Analyst price target in the past 3 months is 34.27.

Each month's total comprises the sum of three months' worth of ratings.

1CNC Financial Forecast

1CNC Earnings Forecast

Next quarter’s earnings estimate for 1CNC is -€1.01 with a range of -€1.13 to -€0.69. The previous quarter’s EPS was €0.43. 1CNC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 1CNC has Preformed in-line its overall industry.

1CNC Sales Forecast

Next quarter’s sales forecast for 1CNC is €41.69B with a range of €39.53B to €43.34B. The previous quarter’s sales results were €43.18B. 1CNC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 1CNC has Preformed in-line its overall industry.

1CNC Stock Forecast FAQ

What is IT:1CNC’s average 12-month price target, according to analysts?

Based on analyst ratings, Centene’s 12-month average price target is 34.27.

What is IT:1CNC’s upside potential, based on the analysts’ average price target?

Centene has 7.28% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Centene a Buy, Sell or Hold?

Centene has a consensus rating of Hold, which is based on 4 buy ratings, 10 hold ratings and 2 sell ratings.

What is Centene’s share price target?

The average share price target for Centene is 34.27. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €39.11 ,and the lowest forecast is €24.33. The average share price target represents 7.28% Increase from the current price of €31.94.

What do analysts say about Centene?

Centene’s analyst rating consensus is a Hold. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of Centene?

To buy shares of IT:1CNC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Centene (1CNC) Stock Forecast & Price Target

1CNC Analyst Ratings

1CNC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Centene

1CNC Analyst Recommendation Trends

1CNC Financial Forecast

1CNC Earnings Forecast

1CNC Sales Forecast

1CNC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts